There is no cure for Tourette's Syndrome. It has been established that both genetic and environmental factors are involved in causing the disorder. Research has shown evidence that the disorder stems from the abnormal activity of at least one brain neurotransmitter called dopamine.
In the United States, the leading supporter of research for Tourette's Syndrome is the National Institute of Neurological Disorders and Stroke ("NINDS"), which is part of the National Institutes of Health. NINDS supports and conducts research on the brain and central nervous system. A variety of studies and tests are being performed including genetic studies, neuroimaging studies, clinical trials, and epidemiology and clinical science.
The Tourette Syndrome Association ("TSA") is dedicated to serving people with Tourette's and funding scientific research. The TSA has chapters in all fifty states and cooperates with contacts in 45 foreign countries. The TSA also publishes materials for families, researchers, and physicians. It also offers a quarterly newsletter.
The case of Ohio resident Jeff Matovic has attracted media attention. He was diagnosed with Tourette's as a young child. He continued to experience severe symptoms of the disorder through adulthood; with his tics actually worsening. In 2004 at age 33, he underwent an experimental surgery for his disorder.
The procedure involved having two electrodes placed deep inside of his brain. The goal of the surgery was to give him greater control over his limbs and voice. Matovic's once incontrollable body movements are now controlled to the point that he can play basketball, video games, and work on a computer.
Research and new technologies may lead to new treatment methods and hopefully a cure for Tourette's. Education and understanding are always important in managing the condition.